At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 26 enrolled
Drug / intervention
Cannabis +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Behavioral Pharmacology of Cannabis and Nicotine
In Brief
A Phase 1 clinical trial evaluating Cannabis and Nicotine for Cannabis and Nicotine. Completed, enrolled 26 participants across 1 site.
Detailed Summary
This study will evaluate the individual and interactive pharmacokinetic and pharmacodynamic effects of smoked cannabis and nicotine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
Phase 1CompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartSep 2020
Primary CompletionJul 2023
Study CompletionAug 2023
TodayJul 2026
First PostedOct 11, 2019
Enrollment StartSep 15, 2020
Primary CompletionJul 24, 2023
Study CompletionAug 31, 2023
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 6.7 years ago
Interventions
Cannabisdrug
Cannabis will be smoked
Nicotinedrug
Nicotine will be smoked or vaporized